Financhill
Sell
46

CAPR Quote, Financials, Valuation and Earnings

Last price:
$13.20
Seasonality move :
-1.81%
Day range:
$12.86 - $13.68
52-week range:
$3.52 - $23.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
21.31x
P/B ratio:
4.22x
Volume:
813.9K
Avg. volume:
1.5M
1-year change:
103.32%
Market cap:
$614.4M
Revenue:
$22.3M
EPS (TTM):
-$1.20

Earnings Data

Next earnings date for CAPR
May 13
2025
Most recent earnings per share
-$0.16
Missed by $0.07
(Mar 19/2025)
Consensus Estimate
-$0.09
(Mar 19/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CAPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/13/2025 Q1 $3.8M -- -- -$0.31 --
03/19/2025 Q4 $9.9M $11.1M -$0.16 -$0.09 -$0.07
11/13/2024 Q3 $3.6M $2.3M -$0.38 -$0.34 -$0.04
08/07/2024 Q2 $3.7M $4M -$0.35 -$0.33 -$0.02
05/13/2024 Q1 $9.7M $4.9M -$0.31 -$0.11 -$0.20
02/29/2024 Q4 $8M $12.1M $0.02 -$0.09 $0.11
11/14/2023 Q3 -- -- -$0.25 -$0.27 $0.02
08/07/2023 Q2 -- -- -$0.29 -$0.33 $0.04
05/11/2023 Q1 -- -- -$0.31 -$0.32 $0.01
03/15/2023 Q4 -- -- -$0.31 -$0.34 $0.03
11/10/2022 Q3 -- -- -$0.26 -$0.32 $0.06
08/10/2022 Q2 -- -- -$0.29 -- --
05/10/2022 Q1 -- -- -$0.32 -- --
03/10/2022 Q4 -- -- -$0.26 -- --
11/09/2021 Q3 -- -- -$0.17 -- --
08/12/2021 Q2 -- -- -$0.21 -- --
05/13/2021 Q1 -- -- -$0.23 -- --
03/11/2021 Q4 -- -- -$0.21 -- --
11/12/2020 Q3 -- -- -$0.20 -- --
08/06/2020 Q2 -- -- -$0.23 -- --
05/14/2020 Q1 -- -- -$0.30 -- --
03/18/2020 Q4 -- -- -$0.34 -- --
09/30/2019 Q3 -- -- -$0.43 -- --
06/30/2019 Q2 -- -- -$0.59 -- --
03/31/2019 Q1 -- -- -$0.75 -- --
12/31/2018 Q4 -- -- -$1.10 -- --
11/13/2018 Q3 -- -- -$1.35 -- --
08/09/2018 Q2 -- -- -$1.42 -- --
05/10/2018 Q1 -- -- -$1.40 -- --
03/14/2018 Q4 -- -- $4.20 -- --
11/08/2017 Q3 -- -- -$1.20 -- --
08/10/2017 Q2 -- -- -$1.60 -- --
05/15/2017 Q1 -- -- -$1.70 -- --
03/15/2017 Q4 -- -- -$2.10 -- --
11/10/2016 Q3 -- -- -$2.90 -- --
08/15/2016 Q2 -- -- -$2.60 -- --
03/31/2016 Q1 -- -- -$2.60 -- --
12/31/2015 Q4 -- -- -$2.10 -- --
09/30/2015 Q3 -- -- -$1.80 -- --
06/30/2015 Q2 -- -- -$1.90 -- --
03/31/2015 Q1 -- -- -$2.30 -- --

Capricor Therapeutics Earnings Questions

  • How Much did Capricor Therapeutics Generate in Revenue Last Quarter?

    Capricor Therapeutics reported $11.1M worth of top line sales in its most recent quarter.

  • Did Capricor Therapeutics Beat Earnings Last Quarter?

    Capricor Therapeutics announced earnings per share of -$0.16 which represents a miss of analyst forecast a -$0.09 per share.

  • Is Capricor Therapeutics Profitable?

    Capricor Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Capricor Therapeutics EPS Next Year?

    Capricor Therapeutics's earnings are forecast to decrease from -$1.15 per share to -$1.07 per share next year representing a decrease of -79.78%.

  • When is Capricor Therapeutics's Earnings Date?

    Capricor Therapeutics's next earnings date is May 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Diamondback Energy a Good Stock to Buy?
Is Diamondback Energy a Good Stock to Buy?

Diamondback Energy (FANG) is a lesser-known diamond in the rough…

What Is Hindsight Bias In Investing?
What Is Hindsight Bias In Investing?

You’ve probably heard the expression “hindsight is 20/20.” That saying…

Is Rivian a Good Stock a Buy?
Is Rivian a Good Stock a Buy?

Rivian Automotive (RIVN) had an initial IPO of close to…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
29
UNF alert for Mar 26

UniFirst [UNF] is up 0.24% over the past day.

Sell
30
KEQU alert for Mar 26

Kewaunee Scientific [KEQU] is down 1.45% over the past day.

Buy
82
EPAC alert for Mar 26

Enerpac Tool Group [EPAC] is down 3.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock